| |
| |
|
|
R E S O L U T I O N
|
|
|
WHEREAS, Dr. Michael Douglas has been selected to serve as |
|
|
the executive director of the Texas Life-Sciences Collaboration |
|
|
Center in Georgetown; and |
|
|
WHEREAS, A veteran scientist with experience in academia and |
|
|
the pharmaceutical industry, Dr. Douglas laid the foundation for |
|
|
his career at Southwestern University, where he earned degrees in |
|
|
chemistry and biology before receiving his doctorate in |
|
|
biochemistry and molecular biology from Saint Louis University; and |
|
|
WHEREAS, Following graduation, Dr. Douglas joined the |
|
|
faculties at The University of Texas Southwestern Medical Center in |
|
|
Dallas and the UT Health Science Center in San Antonio; relocating |
|
|
to the East Coast later on, he served as the chair of the Department |
|
|
of Biochemistry and Biophysics at the University of North Carolina |
|
|
School of Medicine; and |
|
|
WHEREAS, Returning to St. Louis, Dr. Douglas transitioned to |
|
|
the private sector to become the CEO of Sigma Diagnostics, held high |
|
|
positions with two other pharmaceutical companies there, then |
|
|
rejoined the academic world in 2002 as associate vice chancellor |
|
|
for research and director of the Office of Technology Management at |
|
|
Washington University; in 2006, Dr. Douglas was named the director |
|
|
of UAMS BioVentures, a life science business incubator affiliated |
|
|
with the University of Arkansas for Medical Sciences; and |
|
|
WHEREAS, This distinguished microbiologist has advanced the |
|
|
knowledge of his chosen profession by publishing nearly 100 |
|
|
scientific papers, and he holds two patents for discovering new |
|
|
ways to use a compound in biopharmaceutical compositions; Dr. |
|
|
Douglas is also helping Southwestern create a master's degree |
|
|
program in translational medicine; and |
|
|
WHEREAS, Highly respected by his peers, he has served on the |
|
|
board of directors of numerous biotechnology firms, including |
|
|
Novactyl, Inc., U.S. Canadian Biofuels, and Agri Energy Limited; |
|
|
Dr. Douglas has also lent his considerable expertise to the boards |
|
|
of the Central Arkansas Biotechnology Park Authority, the Academy |
|
|
of Science of St. Louis, the Center for Emerging Technologies, the |
|
|
Saint Louis University Parks College of Engineering, Aviation, and |
|
|
Technology, and Southwestern University; and |
|
|
WHEREAS, Dr. Michael Douglas brings an impressive record of |
|
|
experience and achievements to his new position, and he will |
|
|
undoubtedly inspire his colleagues and business collaborators with |
|
|
his exceptional leadership skills and commitment to scientific |
|
|
achievement; now, therefore, be it |
|
|
RESOLVED, That the House of Representatives of the 83rd Texas |
|
|
Legislature hereby congratulate Dr. Michael Douglas on being named |
|
|
executive director of the Texas Life-Sciences Collaboration Center |
|
|
and extend to him sincere best wishes for continued success; and, be |
|
|
it further |
|
|
RESOLVED, That an official copy of this resolution be |
|
|
prepared for Dr. Douglas as an expression of high regard by the |
|
|
Texas House of Representatives. |